We investigated muscle and plasma carnitine concentrations in children to establish reference intervals for use following biopsy of skeletal muscle.
Introduction
Carnitine (3-hydroxy-4-trimethylammonium butyrate) plays an essential role in the transfer of longchain fatty acids from the cytoplasm of a cell into the mitochondrion, where they undergo b-oxidation. Carnitine has important roles in intermediary metabolism such as the conjugation of acyl-CoA intermediates in order to replenish intramitochondrial CoA. 1 In humans, the body stores of carnitine are supplied both from dietary sources and through synthesis in the liver, kidney and brain. Other tissues import carnitine via carnitine transporters, which are present in the plasma membranes of cells. The growing fetus is provided with substantial amounts of carnitine by transfer across the placenta. 2 Preterm newborns have a lower capacity to synthesize carnitine in the liver because of their limited generation of 3-hydroxy-6-N-trimethyllysine, a precursor of carnitine. 3 Although preterm newborns have a g-butyrobetaine hydrolysase activity that is only 12% of the adult's capacity for carnitine synthesis in the liver, this is not considered to be rate-limiting. 4 The skeletal muscle pool of carnitine is estimated to contain 495% of the total body pool, that of other organs about 2% and about 0Í5% in extracellular £uid. 5 In addition, di¡erent inherited and acquired diseases that cause alterations in carnitine status can a¡ect infants and children. 6 Given the lack of speci¢city of clinical symptoms pointing to carnitine de¢ciency, the availability of methods for measuring carnitine concentrations not only in plasma but also in skeletal muscle tissue is important. Plasma values do not always re£ect the tissue carnitine content.
The aims of this study were: to establish reference intervals for the muscle carnitine content in cases where the muscle biopsy samples were obtained during surgery and not at autopsy, which has not been reported earlier; to gain further knowledge about carnitine physiology as opposed to carnitine`insu¤ciency/de¢ciency'. Neonates and children up to 14 years of age without evidence of any inherited metabolic disease were investigated.
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Materials and methods
Patients
The study comprised 31 metabolically healthy children with a diagnosis of inguinal hernia or undescended testis and 19 newborn infants with various oesophagogastrointestinal malformations, all of whom underwent elective surgery. At the beginning of surgery, when the patients were under general anaesthesia and were only receiving glucose, a muscle biopsy sample was taken as an open biopsy with a scalpel. At the same time a blood sample was drawn from a peripheral vein into a vacutainer tube with lithium heparin and centrifuged at ‡ 48C. The muscle samples were rapidly frozen into a mixture of alcohol and dry ice.
The children were divided into six groups according to age: group 1, 52 days (3-31 h), nˆ19; group 2, 1 to 512 months, nˆ7; group 3, 1 to 52 years, nˆ4; group 4, 2 to 55 years, nˆ6; group 5, 5 to 511 years, nˆ9; group 6, 11-14 years, nˆ5. The parents and the older children received verbal and written information about the study before it began and gave their consent. This study was approved by the Ethics Committee of the Faculty of Medicine, Uppsala University.
Methods
The muscle samples, which were stored at 7728C, were freeze-dried and dissected to remove £akes of connective tissue, blood and fat. An aliquot was mixed with an equal volume of 100 mmol/ L NaOH and left overnight. After centrifugation, non-collagen protein was measured in the supernate. The powder was sonicated and aliquots were taken for analysis. 7 Aliquots of plasma were extracted with chloroform-methanol (3:2, v/v). Carnitine was measured by an enzymatic radioisotopic method, with free and total carnitine being determined before and after alkaline hydrolysis, respectively. 7, 8 The carnitine content in muscle tissue was referred to two reference bases, dry weight and non-collagen protein. 7 
Statistical analysis
Non-parametric statistics, Mann-Whitney, Kruskal-Wallis one-way analysis of variance, Spearman's co-e¤cient of rank correlation and stepwise regression analysis were used to compare the carnitine results. Statistica (StatSoft 1 Scandinavia AB, Uppsala, Sweden) was used for the analyses.
Results
The median concentrations of muscle and the plasma carnitine are shown in Tables 1 and 2, in which the values for the older groups have been pooled. The total and free carnitine concentrations in skeletal muscle tissue were higher in groups 3-6 than in groups 1 and 2. The ratio of free to total carnitine was lower and that of acylcarnitine to free carnitine higher in the two youngest groups than in the older children. An accumulation of carnitine occurred in muscle tissue during the ¢rst year (see Fig. 1 ). There was no signi¢cant relationship between the carnitine concentrations in plasma and muscle tissue.
A positive signi¢cant relationship was found between total carnitine (Pˆ0Í002) and acylcarnitine (Pˆ0Í002) (not shown) content in skeletal muscle and gestational weeks in the youngest group (see Fig.  2 ). No such relationship with birth weight was found. Relation between total muscle carnitine concentration and gestational age in group 1 (52 days of age). Spearman rank correlation coef cient (r s ) was 0 ¢ 692 (P50 ¢ 01) for gestational age and 0 ¢ 453 (Pˆ0 ¢ 06) for birth weight (not shown). Further analysis with stepwise regression showed that only the relation to gestational age remained statistically signi cant. The regression line is yˆ1 ¢ 43x747.
Discussion
None of the children in this study had diagnosed conditions that would in£uence their metabolism. The biopsy specimens were taken at the beginning of surgery, when the children were under general anaesthesia. The carnitine content was expressed using two units of reference as no single one is entirely adequate. This is because both reference bases can be in£uenced by various physiological and pathophysiological factors. 7 In newborn infants, hardly any exogenous carnitine will have been supplied and their carnitine status will have relied heavily on the transport of placental carnitine. 2 In the present study, the importance of this source in the newborn group was indicated by the signi¢cant positive relationship found between the total muscle carnitine content and gestational age in spite of the short range of gestational ages (i.e. 34 -41 weeks). No such relationship was found for plasma carnitine. In other studies, in which samples were obtained at autopsy at a wider range of gestational ages, positive relationships between the total muscle carnitine content and gestational age have been found and negative relationships between plasma carnitine and gestational age. 9, 10 This is consistent with the ¢nding of higher plasma carnitine concentrations in preterm than in full-term neonates. 9 Accretion of carnitine in other tissues during the ¢rst year of life, especially during the ¢rst few months, has also been observed in studies with tissue samples obtained at autopsy. 10, 11 Plasma carnitine concentrations show the same age-dependent pattern. 12 In the present study, the ratio of acylcarnitine to free carnitine was found to be high during the ¢rst year in both skeletal muscle tissue and plasma. The fact that a higher ratio was seen in skeletal muscle rules out the ¢nding being due to known di¡erences in the renal handling of free and acyl carnitines, respectively. These age-dependent patterns may be related to maturation processes and to metabolic functions. Moreover, preterm and newborn infants are dependent on exogenous carnitine, as the plasma and tissue carnitine concentrations decrease if no carnitine is given exogenously 13, 14 but are maintained when the infant's food contains carnitine. 15 Low plasma carnitine concentrations have also been noted in older children on total parenteral nutrition over periods of several years. 13 Moreover, carnitine de¢ciency can be part of a number of inherited and acquired diseases. Defects in carnitine biosynthesis have not been reported to date. Primary carnitine de¢ciency is caused by defective carnitine transport. Reduced carnitine concentration in tissue and plasma are caused by insu¤cient carnitine uptake activity from plasma and impaired reabsorption in the kidney, respectively. Other causes are certain therapeutic drugs 16 and a number of inherited metabolic disorders. In these conditions, increased rates of formation and elimination of the particular acylcarnitine contribute to a depletion of carnitine. In such cases, the concentration of plasma carnitine, especially of free carnitine, and the degree of acylation are considered to be markers of`carnitine de¢ciency' and carnitine insu¤ciency'. 17, 18 Low plasma carnitine concentrations are frequently observed in critically ill children 19 and our study shows that a few remarkably low values can also be found in children who are not metabolically disturbed.
In conclusion, the present results demonstrate that the carnitine concentration in skeletal muscle tissue is greatly dependent on the gestational age in newborns. The accumulation of carnitine in skeletal muscle tissue continues during the ¢rst year of life, after which the concentration remains essentially constant. Some very low carnitine concentrations were observed both in plasma and in muscle tissue without evidence of an inherited metabolic disease in the child. Further studies are needed, as the clinical signi¢cance of low carnitine concentrations is not known.
